Moderna Inc MRNA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 06/24/21 EDT
220.03quote price arrow up+220.03 (UNCH)
Volume
93,778
Close
220.14quote price arrow up+8.10 (+3.82%)
Volume
7,971,370
52 week range
54.21 - 227.71

...

Loading . . .
  • Open214.38
  • Day High221.49
  • Day Low213.46
  • Prev Close220.14
  • 52 Week High227.71
  • 52 Week High Date06/07/21
  • 52 Week Low54.21
  • 52 Week Low Date09/08/20

Key Stats

  • Market Cap88.393B
  • Shares Out401.53M
  • 10 Day Average Volume8.68M
  • Dividend-
  • Dividend Yield-
  • Beta1.49
  • YTD % Change110.72

KEY STATS

  • Open214.38
  • Day High221.49
  • Day Low213.46
  • Prev Close220.14
  • 52 Week High227.71
  • 52 Week High Date06/07/21
  • 52 Week Low54.21
  • 52 Week Low Date09/08/20
  • Market Cap88.393B
  • Shares Out401.53M
  • 10 Day Average Volume8.68M
  • Dividend-
  • Dividend Yield-
  • Beta1.49
  • YTD % Change110.72

RATIOS/PROFITABILITY

  • EPS (TTM)1.25
  • P/E (TTM)175.52
  • Fwd P/E (NTM)7.83
  • EBITDA (MRQ)672.52M
  • ROE (MRQ)21.84%
  • Revenue (MRQ)2.732B
  • Gross Margin (MRQ)84.44%
  • Net Margin (MRQ)21.89%
  • Debt To Equity (MRQ)4.77%

EVENTS

  • Earnings Date08/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO4:1004:10
Jefferies' Michael Yee on heart inflammation linked to Covid vaccines

Profile

MORE
Moderna, Inc. is engaged in transformative medicines based on messenger ribonucleic acid (mRNA). It has created a platform to improve the underlying pharmaceutical properties of our mRNA medicines. Its platform consists of three areas: mRNA technologies, delivery technologies, and manufacturing processes. It is pursuing mRNA science to minimize the undesirable activation of the immune system by mRNA and to maximize the potency of mRNA once in the target cells. It has advanced...
Noubar Afeyan Ph.D.
Non-Executive Chairman
Stephane Bancel
Chief Executive Officer
Stephen Hoge M.D.
President
David Meline
Chief Financial Officer
Juan Andres
Chief Technology Officer
Lori Henderson J.D.
General Counsel
Address
200 Technology Sq
Cambridge, MA
02139-3578
United States

Top Peers

SYMBOLLASTCHG%CHG
ILMN
Illumina Inc
468.07-1.06-0.23%
BNTX
BioNTech SE
227.79-1.71-0.75%
GMAB
Genmab A/S
41.97+0.16+0.38%
INCY
Incyte Corp
86.13+1.00+1.17%
CRL
Charles River Laboratories International Inc
366.78-0.17-0.05%